The Florida Breast Cancer Foundation (FBCF), along with those who generously support us with their talent, time, and resources, is working to better the lives of those facing breast cancer in the Florida community. Thanks to the continuing support of Floridians who have purchased the End Breast Cancer specialty license plate, along with the Foundation’s network of breast cancer supporters, survivors, and advocates fighting to end the suffering caused by breast cancer, we have been able to award over $10 million dollars in dedicated funding for education and research programs in the state of Florida.
Only through research will breast cancer be defeated and FBCF continues to challenge the scientific community to design innovative research that will foster new directions for, address neglected issues in, and bring new investigators to the field of breast cancer research. FBCF focuses its funding on research projects that have the potential to make a significant impact on breast cancer, particularly in multidisciplinary and/or multi-institutional collaborations.
2026 Priority Areas:
1. Basic, clinical (including novel diagnostic/therapeutic modalities), and translational breast cancer research.
2. Understanding the links between environmental factors and breast cancer in Florida.
3. Novel epidemiological studies to provide insight on opportunities for improving breast cancer detection and treatment in Florida.
4. Psycho-immunologic mechanisms and breast cancer progression: implications for improving outcomes.
5. Innovative awards and idea grants.
All applications must cover at least one of the priority areas.
Application Window is Closed
Please check back for the next opportunity to apply.
Sign up for FBCF Funding Alerts to stay up-to-date
about future grant opportunties.
SCIENTIFIC GRANT AWARDS CURRENTLY BEING FUNDED (2025-2026)
- University of Central Florida Research Foundation, Inc. - Dr. Otto Phanstiel
Immune adjuvant therapy for the treatment of triple negative breast cancer - University of Florida - Dr. Jianrong Lu
Design of immunogenic recombinant AAVs for breast cancer immunotherapy - H. Lee Moffitt Cancer Center & Research Institute, Inc - Dr. Nancy Gillis
Evidence-based monitoring of clonal hematopoiesis in treatment for breast cancer - University of Florida - Dr. Brian Law
Isoform-Selective Disulfide Isomerase Inhibitors for Overcoming Drug Resistance - H. Lee Moffitt Cancer Center & Research Institute, Inc - Dr. David Morse
Tenascin-C targeted alpha-particle therapy for metastatic breast cancer - University of Central Florida Research Foundation, Inc. - Dr. Needa Brown
Cold-to-Hot: Reprogramming breast tumor microenvironments - University of Florida - Dr. Ryan Kolb
Targeting ANGPTL4 in combination with immunotherapy in basal-like breast cancer - University of Miami - Miller School of Medicine - Dr. Mariana Cooke
The oncogenic DAG-PKC pathway as an actionable vulnerability in TNBC - Nova Southeastern University - Dr. Jean Latimer
Ancestry-specific Changes to Breast Cells After Exposure to S. Florida Chemicals
To learn more about the above grants that are currently being funded, click here.
To see past grant recipients and research projects that have been funded, please visit our Scientific Research Grants page.